Literature DB >> 23127577

Behavioural hyperventilation as a novel clinical condition associated with central sleep apnoea: a report of three cases.

Dirk Pevernagie1, An Mariman, Nele Vandenbussche, Els Tobback, Sebastiaan Overeem, Liesbeth Delesie, Hennie Janssen, Dirk Vogelaers.   

Abstract

Central sleep apnoea (CSA) is a disorder characterised by repetitive episodes of decreased ventilation due to complete or partial reduction in the central neural outflow to the respiratory muscles. Hyperventilation plays a prime role in the pathogenesis of CSA. Chronic heart failure and dwelling at high altitude are classical conditions in which CSA is induced by hyperventilation. Hyperventilation syndrome (HVS) is a prevalent behavioural condition in which minute ventilation exceeds metabolic demands, resulting in haemodynamic and chemical changes that produce characteristic dysphoric symptoms. HVS is frequently caused by anxiety disorders and panic attacks. Until now, medical literature has focussed primarily on daytime symptoms of behavioural hyperventilation. It is currently unknown how this condition may affect sleep. Three cases are reported in which behavioural hyperventilation was associated with occurrence of significant central sleep apnoea, which was not present during normal tidal breathing in steady sleep. Therefore, behavioural hyperventilation should be added to the list of known clinical conditions associated with CSA.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23127577     DOI: 10.1016/j.sleep.2012.08.007

Source DB:  PubMed          Journal:  Sleep Med        ISSN: 1389-9457            Impact factor:   3.492


  3 in total

1.  Behavioral Hyperventilation and Central Sleep Apnea in Two Children.

Authors:  Thomas P Johnston; Jade Tam-Williams; Margaret Schmandt; Anand C Patel; Claudia Cleveland; Ferdinand Coste; James S Kemp
Journal:  J Clin Sleep Med       Date:  2015-04       Impact factor: 4.062

2.  Sleep Apnea and Risk of Panic Disorder.

Authors:  Vincent Yi-Fong Su; Yung-Tai Chen; Wei-Chen Lin; Li-An Wu; Shi-Chuan Chang; Diahn-Warng Perng; Wei-Juin Su; Yuh-Min Chen; Tzeng-Ji Chen; Yu-Chin Lee; Kun-Ta Chou
Journal:  Ann Fam Med       Date:  2015 Jul-Aug       Impact factor: 5.166

Review 3.  Sleep disturbance in PTSD and other anxiety-related disorders: an updated review of clinical features, physiological characteristics, and psychological and neurobiological mechanisms.

Authors:  Anne Richards; Jennifer C Kanady; Thomas C Neylan
Journal:  Neuropsychopharmacology       Date:  2019-08-23       Impact factor: 7.853

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.